Status:
UNKNOWN
Influence of Caffeine Therapy in Preterm Infants
Lead Sponsor:
Marmara University
Conditions:
Caffeine; Sleep Disorder
Eligibility:
All Genders
28-34 years
Brief Summary
The development of sleep wake cycles is indicative of child's neurocognitive functions. Caffeine therapy is commonly used in neonatal intensive care units for treatment of apnea of prematurity (AOP), ...
Detailed Description
Methylxanthines have been prescribed in preterm infants to treat and prevent Apnea of Prematurity (AOP), for extubation success, for reduction of incidence of BPD, need for treatment of PDA, retinopat...
Eligibility Criteria
Inclusion
- Preterm infants born between 28 to 34 gestational weeks admitted to the Marmara University Neonatal Intensive Care Unit (NICU)
Exclusion
- perinatal asphyxia intraventricular hemorrhage grade 3 or higher retinopathy of prematurity(ROP) of stage 3 or higher major congenital anomalies infants using sedative or anticonvulsant drugs at the time of data collection
Key Trial Info
Start Date :
May 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2021
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04376749
Start Date
May 1 2020
End Date
May 1 2021
Last Update
May 6 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Marmara University School of Medicine
Istanbul, Turkey (Türkiye)